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effects with doxophylline indicates that the drug can be 
used safely and effectively in the treatment of chronic 
obstructive pulmonary disease (COPD).[3] Doxophylline 
inhibits phosphodiesterase (PDE IV) activities with the 
consequent increase of cyclic AMP, which determines 
relaxation of the smooth musculature. Doxophylline 
appears to have decreased affinities toward adenosine A1 
and A2 receptors, which may account for the better safety 
profile of the drug. Doxophylline does not interfere with 
calcium influx into the cells or antagonize calcium channel 
blockers.[4] Unlike aminophylline, it has low secretagogue 
activity and is suitable for asthmatic patients with peptic 
ulcer disease.[5]
INTRODUCTION
Doxophylline is chemically designated as 7(1, 3 dioxolone-
2-yl methyl) theophylline. Presence of a dioxolane group 
in position 7 differentiates it from theophylline.  [1] The 
chemical structure of Doxophylline is provided herewith 
[Figure 1].[2] 
It is a new antibronchospastic drug recently introduced 
in therapy, with pharmacological properties like 
theophylline, a potent adenosine receptor antagonist. 
Doxophylline does not affect gastric acid secretion, either 
in vivo or in vitro, unlike theophylline. The lack of side-
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ABSTRACT
Two methods are described for determination of Doxophylline in a solid dosage form. The first method was 
based on ultraviolet (UV)-spectrophotometric determination of the drug. It involves absorbance measurement 
at 274 nm (λmax of Doxophylline) in 0.1 N hydrochloric acid. The calibration curve was linear, with the correlation 
coefficient between 0.99 and 1.0 over a concentration range of 0.20–30 mg/ml for the drug. The second method 
was based on high-performance liquid chromatography (HPLC) separation of the drug in reverse-phase mode 
using the Hypersil ODS C18 column (250 X 4.6 mm, 5 mm). The mobile phase constituted of buffer acetonitrile 
(80:20) and pH adjusted to 3.0, with dilute orthophosphoric acid delivered at a flow rate 1.0 ml/min. Detection 
was performed at 210 nm. Separation was completed within 7 min. The calibration curve was linear, with the 
correlation coefficient between 0.99 and 1.0 over a concentration range of 0.165–30 mg/ml for the drug. The 
relative standard deviation was found to be <2.0% for the UV-spectrophotometry and HPLC methods. Both 
these methods have been successively applied to the solid dosage pharmaceutical formulation, and were fully 
validated according to ICH guidelines.
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Doxophylline is indicated for the treatment of bronchial 
asthma and COPD.[6]
Some analytical methods for quantitative determination 
of Doxophylline in pharmaceutical formulations 
are described in the literature, like ultraviolet (UV)-
spectrophotometry[7] and LC-MS (Liquid Chromatography-
Mass Spectroscopy).  [8-  10] At present, no high-performance 
liquid chromatography (HPLC) and UV-spectrophotometric 
methods are reported for the estimation of Doxophylline 
in a tablet dosage form. The purpose of this work is to 
develop and validate the proposed methods for routine 
analysis in a quality control laboratory.
EXPERIMENTAL PROCEDURE
Instrument and condition
1.  UV-visible spectrophotometer - Model UV-1700 
(Shimadzu, Tokyo, Japan).
2.  HPLC system - Shimadzu LC 2010C integrated system 
equipped with quaternary gradient pump, 2010C UV-VIS 
detector, 2010C column oven and 2010C programmable 
auto sampler controlled by CLASS-VP software. 
(SHIMADZU USA Manufacturing Inc, 1900, SE 4th 
Ave, Canby, OR, 97013-4348, North America, USA)
3.  Analytical column - Hypersil ODS C18 (250 X 4.6 mm, 
5 mm particle size), (Weber Consulting, Attila u. 38/b. 
H-2132 Göd, Hungary)
4.  Detector - UV visible
5.  Chromatographic parameters- Detection at 210 nm, 
flow rate 1.0 ml/min.
6.  Mobile phase - Potassium dihydrogen phosphate 
(pH 3.0 ± 0.2 adjusted with orthophosporic acid)–
acetonitrile (80:20, v/v).
7.  Diluent - 0.1 N hydrochloric acid.
Reagents
1.  Doxophylline reference standard - Assigned purity 
99.24% (Cadila Healthcare Limited, Ankleshwar, 
Gujarat, India).
2.  Acetonitrile - AR grade (Spectrochem), Spectrochem 
Private Limited, Office 221, 2nd Floor, Anand Bhuvan, 
17, Babu Genu Road, Princess Street, MUMBAI - 400 
002.
3.  Orthophosphoric acid - AR grade (E-Merck Limited), 
E-Merck (India) Ltd, Shiv Sagar Estate, `A’, Dr. A B 
Road, Worli, Mumbai, 400018, India
4.  Commercially available Doxophylline tablet - Claimed 
to contain 800 mg of the drug. Procured from Zydus 
Cadila, Ahmedabad, Gujarat, India.
Standard preparation
For UV-spectrophotometric and HPLC methods
Standard stock solution of 400 µg/ml was prepared by 
dissolving 40 mg working standard of Doxophylline in 
100 ml of diluent. The working standard solution of 
Doxophylline had a final concentration of 20 µg/ml 
and was prepared by appropriate dilution from the stock 
solution.
Sample preparation
For UV-spectrophotometric and HPLC methods
Twenty tablets were weighed and crushed into fine powder. 
An accurately weighed quantity of powder equivalent to 
about 125 mg of Doxophylline was transferred into a 250 
ml volumetric flask. Add 100 ml of diluent and sonicate 
it for 30 min with continuous shaking. Make the volume 
up to the mark with 0.1 N HCl. This solution was filtered 
through a 0.45 µm HVLP nylon filter. Make an appropriate 
dilution to get the final concentration of Doxophylline 20 
μg/ml . Appropriated aliquots were subjected to the above 
methods and the amount of Doxophylline was determined.
UV-spectrophotometric method
Construction of  the calibration curve
λmax of Doxophylline (20 µg/ml) was determined by 
scanning the drug solution in diluent and was found to 
be at 274 nm. To construct Beer’s plot for Doxophylline, 
dilutions were made in diluent using stock solution at 
different concentration (4, 12, 16, 20, 24, and 30 µg/ml) 
levels. The drug followed linearity within the concentration 
range of 4–30 µg/ml.
Assay of  the tablet formulation
Twenty tablets were weighed and crushed into fine powder. 
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An accurately weighed quantity of powder equivalent to 
about 125 mg of Doxophylline was transferred into a 250 
ml volumetric flask. Add 100 ml of diluent and sonicate it 
for 30 min with continuous shaking. Make the volume up 
to the mark with 0.1 N HCl. This solution is then filtered 
through a 0.45-µm HVLP (High Vinyl Liquid Polymer) 
nylon filter. Make appropriate dilution to get the final 
concentration of Doxophylline 20 µg/ml. Appropriated 
aliquots were subjected to the above methods and the 
amount of Doxophylline was determined.
HPLC Method
Construction of  the calibration curve
To construct Beer’s plot for Doxophylline, dilutions were 
made in the diluent using stock solutions at different 
concentration (4, 12, 16, 20, 24 and 30 µg/ml) levels. The 
drug followed linearity within the concentration range of 
4–30 µg/ml for Doxophylline at 210 nm.
Assay of  the tablet formulation
Twenty tablets were weighed and crushed into fine powder. 
An accurately weighed quantity of powder equivalent to 
about 125 mg of Doxophylline was transferred into a 250-
ml volumetric flask. Add 100 ml of diluent and sonicate 
it for 30 min with continuous shaking. Make the volume 
up to the mark with 0.1 N HCl. This solution was filtered 
through a 0.45-µm HVLP nylon filter. Make appropriate 
dilution to get the final concentration of Doxophylline 20 
µg-ml. Appropriated aliquots were subjected to the above 
methods and the amount of Doxophylline was determined.
RESULT AND DISCUSSION
System suitability and system precison (For HPLC)
This parameter has been performed before starting any 
validation parameter each time. The purpose of this 
parameter is to ensure that system is working properly 
and it can be used further for analysis and validation. For 
more details, Table 1.
Linearity
The plot of absorbances against concentration is shown 
in Figures 2 and 3. It can be seen that the plot is linear 
over the concentration range of 0.20–30 µg-ml in UV-
spectrophotometry and 0.165–30 µg/ml in HPLC for 
Doxophylline, with correlation coefficients (r2) of 0.99798 
and 0.99629, respectively. The obtained results are 
presented in Tables 2A and 2B.
Standard and sample solution stability
Standard and sample solution stabilities were evaluated at 
room temperature for 48 h. The relative standard deviation 
(RSD) was found to be below 2.0%. It shows that the 
standard and sample solutions were stable up to 48 h at 
Table 3A: Method precision (for UV-spectrophotometric 
method)
Compound Concentration   
µg/ml  
(n = 6)
Absorbance 
Mean ± 
SEM  
(n = 6)
% assay  
Mean ± 
SEM  
(n = 6)
% RSD 
(n = 6)
Doxophylline  20 0.716 ± 
0.00204
101.75 ± 
0.3535
0.9
Table 1: System suitability and system precision (for HPLC)
Compound Retention time 
(Mean ± SEM)
n T k’
Doxophylline 6.434 ± 0.06217 11034.808 1.22 642.4
n = Theoretical plates, T = Asymmetry, k’ = Capacity factor
Table 2A: Characteristics of the Analytical method derived from the standard calibration curve (for UV-
spectrophotometric method)
Compound LOD µg/ml LOQ µg/ml  
n = 5
Linearity 
range µg/ml
Correlation 
coefficient r2
Residual standard 
regression σ
Slope of regression 
S
Doxophylline 0.07 0.2 4–30 0.99798 0.02569 0.00332
LOD = Limit of detection, LOQ = Limit of quantification
Table 2B: Characteristics of the analytical method derived from the standard calibration curve (for HPLC method)
Compound LOD µg/ml LOQ µg/ml  
n = 5
Linearity range 
µg/ml
Correlation 
coefficient r2
Residual standard 
regression σ
Slope of regression S
Doxophylline 0.05 0.165  4–30 0.99629 27483.89232 26167.08537
LOD = Limit of detection, LOQ = Limit of quantification
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Table 3B: Method precision (for HPLC method)
Compound Concentration  
µg/ml  (n = 6)
Retention time  
Mean ± SEM (n = 6)
% assay  
Mean ± SEM (n = 6)
% RSD  
(n = 6)
Doxophylline   20 5.62 ± 0.0460 101.0 ± 0.4232 1.0
Table 4A: Method accuracy (for UV–spectrophotometric method)
Level Drug added  
(mg)
Drug recovered  
(mg)
% assay (Mean ± SEM)  
(n = 3)
% RSD of assay  
(n = 3)
Doxophylline
50%  62.05  62.41 100.6 ± 0.088 0.2
100% 124.01 123.75 99.8 ± 0.409 0.7
150% 185.88 186.23 100.3 ± 0.266 0.5
room temperature. Please refer, Spectrum of Standard 
which is provided as Figure 4 and Chromatograms of 
Standard and sample which are provided as Figures 5 and 
6 respectively.
Method precision
The RSD for six replicates of the sample solution was 
<2.0%, which met the acceptance criteria established for 
the spectrophotometric and HPLC methods. The obtained 
results are presented in Tables 3A and 3B.
Accuracy
Accuracy was performed at three levels: 50, 100 and 150%. 
Percentage recovery and low RSD value show the accuracy 
of the spectrophotometric and HPLC methods. The data 
are presented in Tables 4A and 4B.
Figure 3: Calibration curve for Doxophylline (high-performance liquid chromatography)
Figure 2: Calibration curve for Doxophylline (for the UV-spectrophotometric method)
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Method ruggedness
Ruggedness test was determined between two different 
analysts, instruments and columns. The value of RSD 
below 2.0% showed ruggedness of the developed 
spectrophotometric and HPLC methods. The results of 
ruggedness are presented in Tables 5A and 5B.
Method robustness
The method was found to be robust as small but deliberate 
changes in the method parameters had no detrimental 
effect on the method performance, as shown in Table 6. 
The content of the drug was not adversely affected by these 
changes, as evident from the low value of RSD, indicating 
that the method is robust.
Specificity
There was no interference from sample placebo, and peak 
purity of Doxophylline was 0.99629. This indicates that the 
developed analytical method was specific for its intended 
purpose.
Figure 4: Spectrum of Doxophylline (20 µg/ml) in 0.1 N hydrochloric 
acid by the ultravioled-visible spectrophotometer
Table 4B: Method accuracy (for HPLC method)
Level Drug added  
(mg)
Drug recovered  
(mg)
%assay (Mean ± SEM) 
(n = 3)
% RSD of assay (n = 3)
Doxophylline
50% 62.05 62.21 100.26 ± 0.448 0.8
100% 124.01 123.41 99.5 ± 0.458 0.8
150% 185.88 186.27 100.2 ± 0.321  0.6
Table 5A: Method ruggedness (for UV-spectrophotometric method)
Compound % assay Mean ± SEM (n = 6) % RSD of assay (n = 6)
Day 1, Analyst-1, Instrument-1 
Doxophylline 101.75 ± 0.3535 0.9
Day 2, Analyst-2, Instrument-2 
Doxophylline 101.01 ± 0.1973 0.5
Table 5B: Method ruggedness (for HPLC method)
Compound % assay Mean ± SEM (n = 6) % RSD of assay (n = 6)
Day 1, Analyst-1, Instrument-1, Column-1
Doxophylline 101.0 ± 0.4232 1.0
Day 2, Analyst-2, Instrument-2, Column-2
Doxophylline 100.05 ± 0.20125  0.5
Table 6: Method robustness (for HPLC method)
Compound % RSD in normal Changed condition (n = 5)
Temperature % RSD normal  % RSD (-5°C) % RSD (+5°C)
Doxophylline 1.0  0.18 1.05
pH % RSD normal % RSD (-0.2 unit) % RSD (+0.2 unit)
Doxophylline 1.0 0.19 0.55
Flow rate % RSD normal % RSD (-10%) % RSD (+10%)
Doxophylline 1.0  0.10 0.19
Mobile phase ratio % RSD normal % RSD (-2%) % RSD (+2%)
Doxophylline 1.0 0.08 0.19
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Figure 5: Chromatogram of the standard solution
DISCUSSION
For UV-spectrophotometric method
The proposed analytical method is simple, accurate and 
reproducible. Doxophylline showed λmax at 274 nm. The 
advantages lie in the simplicity of sample preparation and 
the cost economic reagents used. The contribution of 
another important factor is its limit of detection (LOD). 
Results from statistical analysis of the experimental results 
were indicative of satisfactory precision and reproducibility. 
Hence, this spectrophotometric method can be used 
for analysis of different solid dosage formulations in 
commercial quality control laboratories.
Joshi, et al. J Young Pharm. 2010;2(3): 289-296J Young Pharm Vol 2 / No 3  295
Table 7: Comparison between UV and HPLC Method
Parameter UV method HPLC method
Mechanism Measurement of absorbance of samples 
containing only one absorbing component
Measurement of absorbance and separation 
(partition) of samples containing more than 
one absorbing component at a time
Accuracy and precision Low compared to the RP-HPLC method Very accurate and precise
Cost of analysis Very low High
Reagents/solvents/diluents/mobile phase Use of a polar solvent generally is sufficient Use of mobile phase having a combination of 
either buffer and polar solvent and/or use of 
two polar solvents
Analysis of compounds Polar substances having λmax between 200 and 
400 nm
Substances can be analyzed beyond the limit 
provided in the UV method due to the wider 
variety of the detector being employed
Sensitivity Limited in sensitivity Greater sensitivity (as various detectors can be 
employed)
Instrumentation Easy to operate Compared to the UV method, complex to 
operate
Speed Compared to HPLC, analysis can be completed 
within lesser time
Time required for analysis depends on the 
nature of the molecule to be analyzed
Resolution Low resolution compared to the HPLC 
method. Required to go for first and second 
derivative spectrophotometric methods
Greater resolution (wide variety of stationary 
phases)
Type of test/analysis It can be use as a confirmatory test for a 
particular compound
It is used as a specific identification test for a 
particular compound
Useful at scale Useful at laboratory scale at the primary level Useful at a large scale, where complex 
molecules have to be analyzed
Applications Useful to find out the qualitative parameter, 
like λmax of a particular compound
Useful to find out the quantitative parameters, 
like retention time of a particular compound
Degradation/by products Can be analyzed simultaneously Can be analyzed within one analysis
Calculation Calculations have to be performed manually 
based on the λmax of a particular compound
Calculations are performed by the integrator 
itself
Figure 6: Chromatogram of the sample solution
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For HPLC
Considering the efficiency of HPLC, an attempt has 
been made to develop simple, accurate, precise, rapid and 
economic methods for estimation of Doxophylline in a 
solid dosage form. Thus, the method described enables 
quantification of Doxophylline. The advantages lie in the 
simplicity of sample preparation and the cost-economic 
reagents used. The contribution of another important 
factor is its LOD. Results from statistical analysis of 
the experimental results were indicative of satisfactory 
precision and reproducibility. Hence, this HPLC method 
can be used for the analysis of different solid dosage 
formulations in commercial quality control laboratories.
The comparative advantages and disadvantages of the 
UV-spectrophotometric method and reverse-phase HPLC 
method has been provided herewith.
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